VEGF release is associated with hypoxia in inflammatory arthritis(.)

VEGF release is associated with hypoxia in inflammatory arthritis(.)

Show other versions (1)

Bibliographic Details
Main Authors:	Taylor, P, Miotla, J, Etherington, P, Winlove, P, Young, S, Paleolog, E, Maini, R
Format:	Journal article
Published:	2000

Similar Items

VEGF release is associated with hypoxia in inflammatory arthritis
by: Taylor, P, et al.
Published: (2001)

VEGF release is associated with reduced oxygen tensions in experimental inflammatory arthritis.
by: Etherington, P, et al.
Published: (2002)

Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis.
by: Sivakumar, B, et al.
Published: (2008)

Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis.
by: Miotla, J, et al.
Published: (2000)

Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
by: Ballara, S, et al.
Published: (2001)

The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis.
by: Afuwape, A, et al.
Published: (2002)

Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply
by: Taylor, P, et al.
Published: (2001)

Hypoxia-driven angiogenesis is a key feature of tendon disease in rheumatoid arthritis
by: Sivakumar, B, et al.
Published: (2006)

Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis.
by: Muz, B, et al.
Published: (2009)

VEGF and imaging of vessels in rheumatoid arthritis.
by: Taylor, P
Published: (2002)

Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis.
by: Konisti, S, et al.
Published: (2012)

Decrease in articular hypoxia and synovial blood flow at early time points following infliximab and etanercept treatment in rheumatoid arthritis
by: Fisher, B, et al.
Published: (2016)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
by: Feldmann, M, et al.
Published: (1997)

Is the vasculature a potential therapeutic target in arthritis?
by: Taylor, P, et al.
Published: (2006)

Hypoxia and angiogenesis in rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2005)

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
by: Maini, R, et al.
Published: (2000)

The role of hypoxia in rheumatoid tendon disease
by: Sivakumar, B, et al.
Published: (2005)

Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases.
by: Feldman, M, et al.
Published: (1998)

Future prospects for anti-cytokine treatment.
by: Feldmann, M, et al.
Published: (2000)

ADENOVIRAL DELIVERY OF SOLUBLE VEGF RECEPTOR (sFLT-1) ABROGATES DISEASE ACTIVITY IN MURINE COLLAGEN INDUCED ARTHRITIS
by: Afuwape, A, et al.
Published: (2002)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
by: Maini, R, et al.
Published: (1999)

Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis.
by: Afuwape, A, et al.
Published: (2003)

Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis.
by: Akhavani, M, et al.
Published: (2009)

Hypoxia and VEGF mRNA Expression in Human Tumors
by: Lisa S. Ziemer, et al.
Published: (2001-01-01)

Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
by: Feldmann, M, et al.
Published: (2004)

From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis.
by: Harry, L, et al.
Published: (2003)

Synovial hypoxia inducible factor-1 alpha expression is inversely related to tissue oxygen levels in vivo in inflammatory arthritis
by: Donatien, P, et al.
Published: (2005)

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2000)

Anti-cytokine therapy for rheumatoid arthritis.
by: Maini, R, et al.
Published: (2000)

Understanding the immunology of inflammatory arthritis
by: Taylor, P
Published: (2017)

Immunotherapy for rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2001)

Angiogenesis in rheumatoid arthritis.
by: Paleolog, E
Published: (2002)

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
by: Paleolog, E, et al.
Published: (1998)

MEASUREMENTS OF HYDROGEN AND OXYGEN IN ISOLATED BOVINE INTERVERTEBRAL DISC
by: Bartels, E, et al.
Published: (1995)

The vasculature in rheumatoid arthritis: cause or consequence?
by: Paleolog, E
Published: (2009)

Role of pro-inflammatory cytokines in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (1998)

The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer.
by: Turner, K, et al.
Published: (2002)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
by: Paleolog, E, et al.
Published: (1996)

VEGF Receptor 1 Promotes Hypoxia-Induced Hematopoietic Progenitor Proliferation and Differentiation
by: Jonathan Florentin, et al.
Published: (2022-05-01)

Hypoxia-inducible factor-2α is an essential catabolic regulator of inflammatory rheumatoid arthritis.
by: Je-Hwang Ryu, et al.
Published: (2014-06-01)